Tuberculosis: open trials in South Korea

• NCT07209761

  A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

  Trial Treatment · Phase 3 · Otsuka Pharmaceutical Development & Commercialization, Inc.

  Pusan National University Hospital, Busan · The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon · Asan Medical Center - Pulmonology, Seoul

  Registry updated 2026-10-26

• NCT06714513

  ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74

  Trial Treatment · Phase 1 · Quratis Inc.

  Chung-Ang University Gwangmyeong Hospital, Gwangmyeong · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Yonsei University Severance Hospital, Seoul · Ajou University Hospital, Suwon

  Registry updated 2025-06-17

• NCT06946784

  LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea

  Research · Yonsei University

  Department of Internal Medicine, Yonsei University College of Medicine Division of Pulmonology, Severance Hospital, Yonsei University Health System, Seoul

  Registry updated 2025-04-27

• NCT05381194

  BPaL(M) Regimen for the Treatment of MDR/RR-TB

  Trial Treatment · Phase 4 · Asan Medical Center

  Asan Medical Center, Seoul

  Registry updated 2024-03-15

• NCT04485156

  Treatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)

  Trial Treatment · Phase 3 · Seoul National University Hospital

  Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine, Seoul

  Registry updated 2020-07-24

• NCT02527486

  Seoul National University Airway Registry

  Research · Seoul National University Hospital

  Seoul National University Bundang Hospital, Seongnam-si · Seoul National University Hospital, Seoul · Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

  Registry updated 2015-08-19

All Tuberculosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error